Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

102.60p
   
  • Change Today:
      2.80p
  • 52 Week High: 110.00p
  • 52 Week Low: 73.50p
  • Currency: UK Pounds
  • Shares Issued: 536.76m
  • Volume: 384,762
  • Market Cap: 550.71m
  • RiskGrade: 119
  • Beta: 0.25

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-21 Interim 78.63 16.52 2.99p 0.56p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.21p 16.8 8.4 +2% 1.61p 1.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 167.30 37.30 5.60p 17.8 2.4 +8% 1.65p 1.6%
31-Dec-22 183.90 43.40 6.38p 15.6 1.1 +14% 1.67p 1.6%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 12.31 12.31 14.60 1.31

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 102.60p
Change Today 2.80p
% Change 2.81 %
52 Week High 110.00p
52 Week Low 73.50p
Volume 384,762
Shares Issued 536.76m
Market Cap 550.71m
Beta 0.25
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.21% below the market average86.21% below the market average86.21% below the market average86.21% below the market average86.21% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
53.93% above the market average53.93% above the market average53.93% above the market average53.93% above the market average53.93% above the market average
27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average
Income
50% below the market average50% below the market average50% below the market average50% below the market average50% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
12.68% below the market average12.68% below the market average12.68% below the market average12.68% below the market average12.68% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 30-Nov-2021

Time Volume / Share Price
16:00 152 @ 102.60p
15:57 1,458 @ 102.40p
15:57 880 @ 102.40p
15:57 1,433 @ 102.40p
15:54 480 @ 102.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page